216
Participants
Start Date
August 31, 2013
Primary Completion Date
February 21, 2018
Study Completion Date
August 9, 2018
Mycophenolate mofetil
For the first two weeks, an introductory dose of 500 mg twice a day (BID) orally. After two weeks, the dose will be increased to 1.5 g BID.
Methotrexate
For the first two weeks, an introductory dose of 15 mg/week (7.5mg BID once a week) orally. After two weeks, the dose will be increased to 25 mg/week (12.5mg BID once a week)
Prednisone
All patients enrolled in the study will be initially taking concomitant oral corticosteroids at 1 mg/kg or 60 mg daily, whichever is less. Initial corticosteroid dose will be continued for 2 to 4 weeks at which point prednisone will be gradually tapered. Prednisone will be tapered to and held at 7.5 mg/day for the first 6 months of the study.
Royal Victorian Eye and Ear Hospital, Melbourne
Northwestern University, Chicago
Francis I Proctor Foundation, San Francisco
Oregon Health and Science University - Casey Eye Institute, Portland
Aravind Eye Hospital, Coimbatore
Aravind Eye Hospital, Madurai
Aravind Eye Hospital, Pondicherry
King Khaled Eye Specialist Hospital, Riyadh
Asociacion Para Evita La Ceguera en Mexico, Mexico City
Aravind Eye Hospitals, India
OTHER
Oregon Health and Science University
OTHER
Asociación para Evitar la Ceguera en México
OTHER
Royal Victoria Eye and Ear Hospital
OTHER_GOV
Northwestern University
OTHER
National Eye Institute (NEI)
NIH
King Khaled Eye Specialist Hospital
OTHER_GOV
University of California, San Francisco
OTHER